Peritoneal Dialysis Clinical Trial
Official title:
Understand the Difference Between Clinical Measured Ultrafiltration and Real Ultrafiltration.
NCT number | NCT03864120 |
Other study ID # | ??2018(078) |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 15, 2019 |
Est. completion date | December 30, 2020 |
Verified date | March 2021 |
Source | RenJi Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The importance of ultrafiltration (UF) and fluid status in peritoneal dialysis has been increasingly aware of over the last two decades. There is growing body of observational evidence showing that low UF is related to unfavorable outcome especially in anuric patients. The other side of the problem of UF is excessive fluid removal could volume deplete patients and result in loss of residual renal function and overexposing the membrane to glucose unnecessarily. UF is a double-edged sword. The correct measure of UF is the bottom line of talking about target. Measuring UF is supposed to be simple and straight forward. The most common way of measuring UF in clinical practice was to weight the effluent bag and minus the manufacture announced fill volume. Until about 10 years ago, the society first aware that the measurement error in such way is not acceptable. Overfil (the actual volume of dialysate fill in the bag is more than announced) problem was raised from then. However, there are several other problems around this issue. Firstly, when the product has just been produced overfill is different between manufactory. Secondly, the overfill volume does change over transportation and storage. But it is not clear how big the change is. Thirdly, most of the clinics weight the dialysate effluent rather than measure the volume in CAPD, although the specific gravity of dialysate is clearly not going to be 1g/ml. Taking the fact measuring weight is much easier than measuring volume in CAPD, the question behind is to understand how big the difference is and consequently whether it is acceptable. All the patients enrolled in the study would be asked to collect all dialysate effluent of the day of their routine peritoneal dialysis adequacy study and bring to the hospital. The exact weight of the bag for PET test (2.5% glucose concentration and dwell time of 4 hour) before and after the dwell and volume measured of the effluent. The dialysate electrolyte, glucose, protein and creatinine level would also be measured.
Status | Completed |
Enrollment | 261 |
Est. completion date | December 30, 2020 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. Age >18 years 2. on PD treatment for at least one month 3. signed the consent Exclusion Criteria: 1. Peritonitis or recovery from peritonitis for less than one month. 2. On any intra peritoneal treatment apart from peritoneal dialysis. 3. Evidence of decompensated liver cirrhosis or heart failure. 4. Evidence of extra peritoneal leakage, eg. leakage to thoracic cavity, post peritoneal, hernia. |
Country | Name | City | State |
---|---|---|---|
China | Renji Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
RenJi Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | specific gravity of effluent dialysate is different from water (1g/ml) | To describe the specific gravity of effluent dialysate, the exact weight and volume of effluent dialysate bags in the standard peritoneal equivalent test (PET, 2.5% glucose concentration, 2L, dwell time 4 hours) dwell would be measured in different patients. | For each patient, the outcome would be cross sectional measured at the time the patient does his 6 monthly routine PET test. The data collection time period of the study is 6 month. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04925674 -
Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
|
Phase 1 | |
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Completed |
NCT05149508 -
Intraperitoneal Pressure Measurements in Children
|
||
Not yet recruiting |
NCT04900610 -
The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis
|
N/A | |
Withdrawn |
NCT03019159 -
Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis
|
N/A | |
Recruiting |
NCT01195519 -
The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
|
N/A | |
Recruiting |
NCT06351007 -
Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK)
|
N/A | |
Not yet recruiting |
NCT04628117 -
Effect of Oral Nutritional Supplementation on Oxidative Stress in Protein-energy Wasting Patients With Peritoneal Dialysis
|
N/A | |
Recruiting |
NCT05449067 -
CAPD Versus APD in Nondiabetic Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT03953950 -
Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT02128347 -
Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients
|
N/A | |
Completed |
NCT01209273 -
Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
|
N/A | |
Completed |
NCT00734552 -
Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Renal Function in PD Patients
|
N/A | |
Not yet recruiting |
NCT06096558 -
The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT04413266 -
Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis
|
N/A | |
Not yet recruiting |
NCT06060951 -
Relating Abdominal Complications With Peritoneal Pressure Estimation and Reporting
|
||
Completed |
NCT03980795 -
Exercise in Peritoneal Dialysis Patients (PDEX)
|
N/A | |
Not yet recruiting |
NCT02270229 -
Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.
|
N/A | |
Completed |
NCT02347592 -
Peritoneal Dialysis Catheter Function
|
N/A | |
Withdrawn |
NCT00397358 -
Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
|
Phase 4 |